Appendix 4C Quarterly Activity Report
Mesoblast Operational and Financial Highlights for Quarter Ended March 31, 2021NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited...
Day: April 30, 2021
COMPASS Pathways announces pricing of public offering
London, UK, 30 April 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company...
Remestemcel-L Reduces Mortality in Patients Less Than 65 Years Old With Moderate/Severe COVID-19 ARDS: Topline 60-Day Results From Randomized Controlled Trial
Remestemcel-L reduced mortality through 60 days in the pre-specified population under 65 years oldIn these patients the benefit was further...
The Aesthetic Meeting 2021 Features Guest Lecture from Whole Beauty® Institute
The Chicago-Based Team Will Share Knowledge on Board-Certified Dr. John Q. Cook’s Structural Mastopexy Breast Lift Technique in the SpringCHICAGO,...
Mesoblast Corporate Update
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Vaccitech Announces Pricing of Initial Public Offering
OXFORD, United Kingdom, April 29, 2021 (GLOBE NEWSWIRE) -- Vaccitech plc (“Vaccitech”) (Nasdaq: VACC), a clinical-stage biopharmaceutical company engaged in...
Early Warning Reports Issued Pursuant to National Instrument 62-103 in Connection with the Completion of Private Share Sales
TORONTO, April 29, 2021 (GLOBE NEWSWIRE) -- Jack Burnett, President and a director of Ramm Pharma Corp. ("Ramm" or, the...
ClearPoint Neuro to Announce First Quarter 2021 Results May 11, 2021
SOLANA BEACH, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform...
Pharvaris Reports Full Year 2020 Financial Results and Provides Business Highlights
RAPIDe-1 clinical trial enrolling, evaluating PHVS416 as an oral on-demand therapy for HAEOpen IND for the prophylactic evaluation of PHVS416Strong...
CooperCompanies Announces Release Date for Second Quarter 2021
SAN RAMON, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release second quarter 2021...
Eloxx Pharmaceuticals Adds Additional Treatment Arm to Ongoing Phase 2 Clinical Studies for Cystic Fibrosis
Fifth Treatment Arm to Evaluate Safety of ELX-02 in Combination with Kalydeco (ivacaftor) Reaffirmed Data Readout for First Four Treatment...
Selecta Biosciences Announces Three Presentations at the Upcoming 24th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
WATERTOWN, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
Lexicon Pharmaceuticals to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 6, 2021
THE WOODLANDS, Texas, April 29, 2021 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its first quarter 2021...
Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
EXTON, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today reported its...
LevelJump Announces $1.5 Million Non-Brokered Private Placement with Strategic Investors
Toronto, Ontario--(Newsfile Corp. - April 30, 2021) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC: JMPHF) (FSE: 75J) ("LevelJump" or the...
Core One Labs Appoints Patent Expert, Dr. Dan Polonenko, To Advisory Board
VANCOUVER, BC / ACCESSWIRE / April 29, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the "Company") is pleased to announce...